Skip to content

Positive Psychotherapy and Cognitive Behavioral Therapy in Anxiety Patients - An Evaluation Study of Three Treatment Conditions in an Online Group Setting.

Positive Psychotherapy and Cognitive Behavioral Therapy in Anxiety Patients - An Evaluation Study of Three Treatment Conditions in an Online Group Setting.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027521
Enrollment
165
Registered
2022-02-03
Start date
2022-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F41.1 F41.0 F40.1

Interventions

Group 1: Intervention group 1: Positive psychotherapy Group 2: Intervention group 2: Cognitive behavioral therapy Group 3: Control group: online-based positive psychotherapy with minimal therapeutic s

Sponsors

Paris Lodron Universität Salzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of any of the following anxiety disorders: F40.1: Social anxiety disorder/social phobia; F41.0 rung/social phobia; F41.0 Panic disorder with or without agoraphobia, F41.1 generalized anxiety disorder - sufficient proficiency in the German language - average intellectual capacity (assessment during the the telephone/video-based screening) - sufficient time for weekly sessions and homework - acceptance of the study protocol

Exclusion criteria

Exclusion criteria: - Participation (or planned in the next three months9in psychotherapeutic and/or psychological treatment or counselling, as well as participation in other psychological group services. - Symptoms of major depression, bipolar affective disorder or mania (current as well as anamnestic), psychotic, schizophrenic and/or schizoaffective disorders, acute grief reaction, severe anorexia or bulimia, substance dependencies (alcohol, illicit drugs) - severe personality disorders, especially borderline, narcissistic, anti/dissocial and paranoid personality disorder - acute suicidal tendencies - Switch, dose change, or complete discontinuation of psychotropic drugs in the past or following three months - lack of decision-making ability

Design outcomes

Primary

MeasureTime frame
The study includes three measurement time points, a pre- and post-measurement and a follow-up after three months. The following self-report questionnaires concerning anxiety are given at all three time points: Beck Anxiety Inventory (BAI), Panic and Agoraphobia Scale (PAS), Generalized Anxiety Disorder 7 (GAD-7), Social Anxiety and Social Skills Deficits Questionnaire (SASKO), Anxiety Questionnaire (AF)/Fear Questionnaire (FQ), Patient Health Questionnaire (PHQ-9), ICD-10- Symptom Rating (ISR) to assess general mental abnormality.

Secondary

MeasureTime frame
The study includes three measurement time points, a pre- and post-measurement and a follow-up after three months. The following self-report questionnaires regarding positive outcomes will be given at all three time points: Positive Psychotherapy Inventory (PPTI), Flourishing Scale (FS), Satisfaction with Life Scale (SWLS).

Countries

Austria, Germany

Contacts

Public ContactCatiana Engelhardt

Paris Lodron Universität Salzburg

Catiana.engelhardt@web.de0049 1604039525

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026